10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For The Quarterly Period Ended September 30, 2018

or

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission File Number 333-220144

AGAPE ATP CORPORATION

(Exact name of registrant issuer as specified in its charter)

Nevada	36-4838886
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1705 - 1708, Level 17, Tower 2, Faber Tower, Jalan Desa Bahagia,
Taman Desa, 58100 Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

Registrant’s phone number, including area code (60) 192230099

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES [X] NO [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files).

YES [  ] NO [X]

Indicate by check mark whether the registrant is a large accelerated fler, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer [  ] Accelerated Filer [  ] Non-accelerated Filer [  ] Smaller reporting company [X]

Emerging growth company [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ] No [X]

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

Yes [  ] No [  ]

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class	Outstanding at November 13, 2018
Common Stock, $.0001 par value	376,275,500

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION
ITEM 1.	UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:	F-1
	Condensed Consolidated Balance Sheets as of September 30, 2018 (unaudited) and June 30, 2018 (audited)	F-2
	Condensed Consolidated Statements of Operations and Comprehensive Losses for the Three Months Ended September 30, 2018 and 2017 (unaudited)	F-3
	Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended September 30,2018 (unaudited)	F-4
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2018 and 2017 (unaudited)	F-5
	Notes to the Condensed Consolidated Financial Statements	F-6 - F-15
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	3
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	5
ITEM 4.	CONTROLS AND PROCEDURES	5
PART II	OTHER INFORMATION
ITEM 1	LEGAL PROCEEDINGS	6
ITEM 2	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	6
ITEM 3	DEFAULTS UPON SENIOR SECURITIES	6
ITEM 4	MINE SAFETY DISCLOSURES	6
ITEM 5	OTHER INFORMATION	6
ITEM 6	EXHIBITS	7
	SIGNATURES	8

2

PART I FINANCIAL INFORMATION

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

	Page
Condensed Consolidated Financial Statements
Condensed Consolidated Balance Sheets as of September 30, 2018 (unaudited) and June 30, 2018 (audited)	F-2
Condensed Consolidated Statements of Operations and Comprehensive Losses for the Three Months Ended September 30, 2018 and 2017 (unaudited)	F-3
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended September 30,2018 (unaudited)	F-4
Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2018 and 2017 (unaudited)	F-5
Notes to the Condensed Consolidated Financial Statements	F-6-F-15

F-1

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF SEPTEMBER 30, 2018 AND JUNE 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

	As of			As of
	September 30, 2018			June 30, 2018
	Unaudited			Audited
ASSETS
NON-CURRENT ASSETS
Investment in investee company	$	780,226		$	832,335
Investment in marketable securities		500,000			500,000
Total Non-Current Assets	$	1,280,226		$	1,332,335
CURRENT ASSETS
Cash and cash equivalents	$	3,838,260		$	3,531,255
Account receivables		13,264			-
Prepayments and deposits		372,191			264,941
Total Current Assets	$	4,223,715		$	3,796,196
TOTAL ASSETS	$	5,503,941		$	5,128,531
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Trade payable	$	47,641		$	-
Other payables and accrued liabilities		7,749			19,749
Deposit received		471,931			-
Income tax provision		9,038			5,334
Amount due to a director		3,922			3,922
Amount due to a related party		745			745
Total Current Liabilities	$	541,026		$	29,750
TOTAL LIABILITIES	$	541,026		$	29,750
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding		-			-
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 and 376,275,500 issued and outstanding as of September 30, 2018 and June 30, 2018	$	37,628		$	37,628
Additional paid in capital		5,293,082			5,293,082
Accumulated other comprehensive losses		(1,293	)		(1,293	)
Accumulated losses		(366,502	)		(230,636	)
TOTAL STOCKHOLDERS’ EQUITY	$	4,962,915		$	5,098,781
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	5,503,941		$	5,128,531

See accompanying notes to condensed consolidated financial statements.

F-2

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSSES

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018 and 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

	Three Months Ended September 30,
	2018			2017
REVENUE	$	415,367		$	490,126
COST OF REVENUE		(378,423	)		(444,238	)
GROSS PROFIT	$	36,944		$	45,888
REALISED GAIN ON FOREIGN EXCHANGE		1,597			-
UNREALISED LOSS ON FOREIGN EXCHANGE		(80,029	)		-
OTHER INCOME		24			5
SELLING, GENERAL AND ADMINISTRATIVE AND OPERATING EXPENSES		(38,589	)		(93,350	)
LOSS BEFORE INCOME TAX	$	(80,053	)	$	(47,457	)
SHARE OF RESULT OF INVESTEE COMPANY		(52,109	)		-
		(132,162	)		(47,457	)
TAXATION		(3,704	)		(7,152	)
NET LOSS	$	(135,866	)	$	(54,609	)
Other comprehensive income:
- Foreign currency translation adjustment		-			-
TOTAL COMPREHENSIVE LOSS	$	(135,866	)	$	(54,609	)
Net loss per share- Basic and diluted		(0.00	)		(0.00	)
Weighted average number of common shares outstanding - Basic and diluted		376,275,500			371,350,000

See accompanying notes to condensed consolidated financial statements.

F-3

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

	COMMON STOCK				ADDITIONAL		ACCUMULATED
	Number of shares		Amount		PAID-IN CAPITAL		COMPREHENSIVE LOSS			ACCUMULATED LOSSES			TOTAL EQUITY
Balance as of June 30, 2018 (audited)		376,275,600	$	37,628	$	5,293,082	$	(1,293	)	$	(230,636	)	$	5,098,781
Net loss		-		-		-		-			(135,866	)		(135,866	)
Balance as of September 30, 2018 (unaudited)		376,275,600	$	37,628	$	5,293,082	$	(1,293	)	$	(366,502	)	$	4,962,915

See accompanying notes to condensed consolidated financial statements

F-4

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018 and 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

	Three months ended September 30,
	2018			2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(135,866	)	$	(54,609	)
Adjustments to reconcile net loss to net cash used in operating activities:
Share of result of investee company		52,109			-
Changes in operating assets and liabilities:
Accounts receivables		(13,264	)		(490,466	)
Prepayments and deposits		(107,250	)		-
Accounts payables		47,641			387,052
Other payables and accrued liabilities		(12,000	)		(8,000	)
Deposit received		471,931			-
Income tax provision		3,704			7,152
Amount due to director		-			3,846
Net cash provided by/(used in) operating activities		307,005			(155,025	)
Net change in cash and cash equivalents		307,005			(155,025	)
Cash and cash equivalents, beginning of period		3,531,255			2,312,748
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	3,838,260		$	2,157,723
SUPPLEMENTAL CASH FLOWS INFORMATION
Income taxes paid	$	-		$	-
Interest paid	$	-		$	-

See accompanying notes to condensed consolidated financial statements.

F-5

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

1. DESCRIPTION OF BUSINESS AND ORGANIZATION

Agape ATP Corporation was incorporated on June 1, 2016 under the laws of the state of Nevada.

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

The Company and its subsidiaries are engaged in providing services in the Health and Wellness Industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries and investee company:

	Subsidiary company name	Place and date of incorporation	Particulars of issued capital	Principal activities	Proportional of ownership interest and voting power held
1.	Agape ATP Corporation	Labuan, March 6, 2017	1 share of ordinary share of US$1 each	Investment holding		100	%
2.	Agape ATP International Holding Limited	Hong Kong, June 1, 2017	1 share of ordinary share of HK$1 each	Health and wellness products and health solution advisory services		100	%

	Investee company name	Place and date of incorporation	Particulars of issued capital	Principal activities	Proportional of ownership interest and voting power held
1.	Unreserved Sdn Bhd	Malaysia, August 25, 2008	500,000 shares of ordinary share of RM7 each	Magazines publication and advertising		20	%

(1) Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of these entities unilaterally, and hence the Company has control over these entities.

F-6

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The consolidated financial statements for Agape ATP Corporation and its subsidiaries for the year ended September 30, 2018 and 2017 are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of Agape ATP Corporation and its wholly owned subsidiaries, Agape ATP Corporation and Agape ATP International Holding Limited. Intercompany accounts and transactions have been eliminated in consolidation. The Company has adopted June 30 as its fiscal year end.

Basis of consolidation

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company accounts and transactions have been eliminated upon consolidation.

Use of estimates

Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.

Cash and cash equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents.

Accounts receivable

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

F-7

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

Investment in investee company

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

Investment in marketable securities

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

Deposit received

Deposit received refers to payment received in advance for products which have not yet been delivered. Deposits received is classified on the consolidated balance sheet as current liability.

Revenue recognition

In accordance with Accounting Standards Codification (“ASC”) Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there were no sales return for the three months September 30, 2018.

Cost of revenue

Cost of revenue includes the purchase cost of manufactured goods for sale to customers. It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

Selling, general, administrative and operating expenses

Selling, general, administrative and operating expenses are primarily comprised of travelling and accommodation fees such as petrol, toll and parking.

Income taxes

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

F-8

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

Net income/(loss) per share

The Company calculates net income/(loss) per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

Related parties

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

Foreign currencies translation

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”). In addition, the Company’s subsidiaries in Hong Kong maintain its books and record in its local currency, Hong Kong Dollars (“HKD$”) and Malaysian Ringgit (“MYR”) is the functional currency as being the primary currency of the economic environment in which the entity operates.

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

Translation of amounts from MYR into US$1 and HKD$ into US$1 have been made at the following exchange rates for the respective periods:

	As of and for the three months ended September 30
	2018		2017
Period-end MYR : US$1 exchange rate		4.14		4.22
Period-average MYR : US$1 exchange rate		4.09		4.26
Period-end HKD$ : US$1 exchange rate		7.83		7.81
Period-average HKD$ : US$1 exchange rate		7.85		7.81

F-9

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

Fair value of financial instruments:

The carrying value of the Company’s financial instruments: cash and cash equivalents, account receivables, deposits and prepayment, amount due to a director, and accounts payable and approximate at their fair values because of the short-term nature of these financial instruments.

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Recent accounting pronouncements

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

F-10

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

3. COMMON STOCK

As of September 30, 2018 and June 30, 2018, there are 376,275,500 shares with par value of $0.0001 each of common stock issued and outstanding. There was no common stock issued and outstanding from initial public offering in the period as of September 30, 2018.

There were no stock options, warrants or other potentially dilutive securities outstanding as of September 30, 2018.

F-11

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

4. INVESTMENT IN INVESTEE COMPANY

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. The investment is stated at cost plus profit share in the investee company as at September 30, 2018. Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim, Ms Aniza Helina Akmi Karim, and Mr How Kok Choong are the directors of Unreserved Sdn Bhd. Mr How Kok Choong is the common director of Unreserved Sdn Bhd and the Company.

	As of September 30, 2018			As of June 30, 2018
Cost of investment	$	862,490		$	862,490
Less: share of result of investee company		(82,264	)		(30,155	)
Investment in investee company	$	780,226		$	832,335

5. INVESTMENT IN MARKETABLE SECURITIES

At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.

	As of September 30, 2018		As of June 30, 2018
Cost of investment	$	500,000	$	500,000
Investment in marketable securities	$	500,000	$	500,000

6. CASH AND CASH EQUIVALENTS

As at September 30, 2018, the Company recorded $3,838,260 of cash and cash equivalents which consists of $1,413,947 of cash on hand and $2,424,313 of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits is 2.95% per annum.

7. ACCOUNT RECEIVABLES

Account receivables consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Account receivables	$	13,264	$	-
Total account receivables	$	13,264	$	-

8. PREPAYMENTS AND DEPOSITS

Prepayments and deposits consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Prepaid expenses	$	7,217	$	11,018
Deposits to supplier		364,974		253,923
Total prepaid expenses and deposits	$	372,191	$	264,941

F-12

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

9. TRADE PAYABLE

Trade payable consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Trade payable	$	47,641	$	-
Total trade payable	$	47,641	$	-

10. OTHER PAYABLES AND ACCRUED LIABILITIES

Other payables and accrued liabilities consisted of the following at September 30, 2018 and June 30, 2017:

	As of September 30, 2018		As of June 30, 2018
Accrued audit fees	$	7,000	$	19,000
Accrued professional fees		749		749
Total payables and accrued liabilities	$	7,749	$	19,749

11. DEPOSIT RECEIVED

Deposit received consisted of the following at September 30, 2018 and June 30, 2017:

	As of September 30, 2018		As of June 30, 2018
Deposit received from customer	$	471,931	$	-
Total deposit received	$	471,931	$	-

12. RELATED PARTY TRANSACTIONS

	Three Months Ended September 30, 2018		Three Months Ended September 30, 2017
Revenue:
- Related Party A	$	415,367	$	490,126
Amount due to related party:
- Related Party A	$	745	$	-
Company Secretary Fee:
- Related Party B	$	802	$	-

The director of related party A is the CEO and the Director of the Company.

Related party B is a 4.7% shareholder of the Company.

13. AMOUNT DUE TO A DIRECTOR

As of September 30, 2018 and June 30, 2017, a director of the Company advanced $3,922 to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

F-13

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

14. INCOME TAXES

For the three months ended September 30, 2018 and 2017, the local (United States) and foreign components of income/(loss) before income taxes were comprised of the following:

	Three Months Ended September 30
	2018			2017
Tax jurisdictions from:
- Local	$	(21,497	)	$	(90,745	)
- Foreign, representing
Labuan, Malaysia		(81,004	)		(58	)
Hong Kong		(29,661	)		43,346
Loss before income tax	$	(132,162	)	$	(47,457	)

The provision for income taxes consisted of the following:

	Three Months Ended September 30
	2018		2017
Current:
- Local	$	-	$	-
- Foreign		3,704		7,152
Deferred:
- Local		-		-
- Foreign		-		-
Income tax expense	$	3,704	$	7,152

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

United States of America

Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2018, the operations in the United States of America incurred $383,615 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for September 30, 2018 and June 30, 2018 are $76,559 and $76,045 respectively.

Labuan

Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit or at a fixed rate of RM20,000.

Hong Kong

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income. The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2018 and June 30, 2018:

	As of September 30, 2018			As of June 30, 2018
	(unaudited)			(audited)
Deferred tax assets:
Net operating loss carry forwards
- United States of America	$	76,559		$	76,045
- Hong Kong		-			-
Less: valuation allowance	$	(76,559	)	$	(76,045	)
Deferred tax assets	$	-		$	-

F-14

AGAPE ATP CORPORATION

NOTES TO CONDENSED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(UNAUDITED)

15. CONCENTRATIONS OF RISK

The Company is exposed to the following concentrations of risk:

(a) Major customers

For three months ended September 30, 2018 and 2017, the customers who accounted for 10% or more of the Company’s sales and its outstanding receivable balance at period-end are presented as follows:

	2018		2017		2018			2017			2018		2017
	Revenues				Percentage of revenues						Accounts receivable, trade
Customer A	$	415,367	$	490,126		100	%		100	%	$	13,264	$	490,466
	$	415,367	$	490,126		100	%		100	%	$	13,264	$	490,466

(b) Major vendors

For three months ended September 30, 2018 and 2017, the vendors who accounted for 10% or more of the Company’s purchases and its outstanding payable balance at period-end are presented as follows:

	2018		2017		2018			2017			2018		2017
	Purchases				Percentage of purchases						Accounts payable, trade
Vendor A	$	314,423	$	444,238		83	%		100	%	$	47,641	$	387,052
Vendor B	$	64,000	$	-		17	%		-	%	$	-	$	-
	$	378,423	$	444,238		100	%		100	%	$	47,641	$	387,052

16. SUBSEQUENT EVENTS

The Company has evaluated subsequent events from the balance sheet date through November 13, 2018, the date the Company issued unaudited consolidated financial statements in accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued. During this period, there was no subsequent event that required recognition or disclosure.

F-15

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The information contained in this quarter report on Form 10-Q is intended to update the information contained in our Form 10-K, dated September 27, 2018, for the year ended June 30, 2018 and presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our consolidated financial statements and the notes to the consolidated financial statements included elsewhere in this Form 10-Q.

The following discussion contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We strongly encourage investors to carefully read the factors described in our Form S-1 Amendment No.2, dated October 26, 2017, in the section entitled “Risk Factors” for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this transition report on Form 10-Q. The following should also be read in conjunction with the unaudited Condensed Consolidated Financial Statements and notes thereto that appear elsewhere in this report.

Company Overview

Agape ATP Corporation., a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016. Agape ATP Corporation is a company that operates through its wholly owned subsidiary, Agape ATP Corporation, a company incorporated in Labuan, Malaysia. Our wholly owned subsidiary, Agape ATP Corporation owns 100% of Agape ATP International Holding Limited, the operating Hong Kong company.

Agape ATP Corporation is a company which plans to develop and provide health solution advisory services to our future clients. We will, at least initially, primarily focus our efforts on attracting customers in Malaysia. Our advisory services will center around the “ATP Zeta Health Program”, which is a health program designed to assist in the elimination of various diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition, and advice from skilled dieticians.

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. Our program emphasizes nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

Results of Operation

For the three months ended September 30, 2018 and 2017

Revenues

For three months ended September 30, 2018 and 2017, the Company has generated revenue of $415,367 and $490,126 respectively. The revenue mainly derived from the sale of healthy food products.

Our gross profits for the three months ended September 30, 2018 were $36,944, which is less than $45,888 for three months ended September 30, 2017. We attribute the decrease in revenue and gross profit to decrease of market exposure and the introduction of other new products in 2018. We believe that in order to retain and maintain more customers in the future we must increase our marketing efforts and or develop new products.

Net Loss

Our net loss for three months ended September 30, 2018 were $135,866, while for three months ended September 30, 2017 were $54,609. We attribute the net loss due to unrealized loss in foreign exchange and the increasing cost of goods sold.

3

Liquidity and Capital Resources

For the three months ended September 30, 2018, we had working capital surplus of $3,682,689 consisting of cash and cash equivalents of $3,838,260 as compared to working capital surplus of $3,766,446 and cash and cash equivalents of $3,531,255 as of June 30, 2018.

Cash Provided by/Used in Operating Activities

For the three months ended September 30, 2018, net cash provided by operating activities was $307,005. The operating cash flow performance primarily reflects the deposits received from customer of the Company.

Cash Provided by/Used in Financing Activities

For the three months ended September 30, 2018, there is no net cash provided by or used in financing activities.

Cash Provided by/Used in Investing Activities

For the three months ended September 30, 2018, there is no net cash provided by or used in investing activities.

Credit Facilities

We do not have any credit facilities or other access to bank credit.

Off-balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders as of September 30, 2018.

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

4

ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

ITEM 4 CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures:

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2018. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2018, our disclosure controls and procedures were not effective due to the presence of material weaknesses in internal control over financial reporting.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that, as of September 30, 2018, our disclosure controls and procedures were not effective: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.

Changes in Internal Control over Financial Reporting:

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2018, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

5

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

We know of no materials, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any beneficial shareholder are an adverse party or has a material interest averse to us.

Item 1A. Risk Factors.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information.

None

6

ITEM 6. Exhibits

Exhibit No.	Description
31.1	Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer*
32.1	Section 1350 Certification of principal executive officer *
101.INS	XBRL Instance Document*
101.SCH	XBRL Schema Document*
101.CAL	XBRL Calculation Linkbase Document*
101.DEF	XBRL Definition Linkbase Document*
101.LAB	XBRL Label Linkbase Document*
101.PRE	XBRL Presentation Linkbase Document*

* Filed herewith.

7

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AGAPE ATP CORPORATION
	(Name of Registrant)
Date: November 13, 2018
	By:	/s/ How Kok Choong
	Title:	Chief Executive Officer, President, Director, Secretary and Treasurer
		(Principal Executive Officer)

8

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, HOW KOK CHOONG, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Agape ATP Corporation (the “Company”) for the quarter ended September 30, 2018;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 13, 2018	By:	/s/ How Kok Choong
		HOW KOK CHOONG
		Chief Executive Officer, President, Director, Secretary, Treasurer
		(Principal Executive Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Agape ATP Corporation (the “Company”) on Form 10-Q for the quarter ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: November 13, 2018	By:	/s/ How Kok Choong
		HOW KOK CHOONG
		Chief Executive Officer, President, Director
		(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2018	Nov. 13, 2018
Document And Entity Information
Entity Registrant Name	Agape ATP Corp
Entity Central Index Key	0001713210
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		376,275,500
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019

XML

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2018	Jun. 30, 2018
NON CURRENT ASSETS
Investment in investee company	$ 780,226	$ 832,335
Investment in marketable securities	500,000	500,000
Total Non-Current Assets	1,280,226	1,332,335
CURRENT ASSETS
Cash and cash equivalents	3,838,260	3,531,255
Account receivables	13,264
Prepayments and deposits	372,191	264,941
Total Current Assets	4,223,715	3,796,196
TOTAL ASSETS	5,503,941	5,128,531
CURRENT LIABILITIES
Trade payable	47,641
Other payables and accrued liabilities	7,749	19,749
Deposit received	471,931
Income tax provision	9,038	5,334
Amount due to a director	3,922	3,922
Amount due to a related party	745	745
Total Current Liabilities	541,026	29,750
TOTAL LIABILITIES	541,026	29,750
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 and 376,275,500 issued and outstanding as of September 30, 2018 and June 30, 2018	37,628	37,628
Additional paid in capital	5,293,082	5,293,082
Accumulated other comprehensive losses	(1,293)	(1,293)
Accumulated losses	(366,502)	(230,636)
TOTAL STOCKHOLDERS' EQUITY	4,962,915	5,098,781
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 5,503,941	$ 5,128,531

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2018	Jun. 30, 2018
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	376,275,500	376,275,500
Common stock, shares outstanding	376,275,500	376,275,500

XML

Condensed Consolidated Statements of Operations and Comprehensive Losses (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
REVENUE	$ 415,367	$ 490,126
COST OF REVENUE	(378,423)	(444,238)
GROSS PROFIT	36,944	45,888
REALISED GAIN ON FOREIGN EXCHANGE	1,597
UNREALISED LOSS ON FOREIGN EXCHANGE	(80,029)
OTHER INCOME	24	5
SELLING, GENERAL AND ADMINISTRATIVE AND OPERATING EXPENSES	(38,589)	(93,350)
LOSS BEFORE INCOME TAX	(80,053)	(47,457)
SHARE OF RESULT OF INVESTEE COMPANY	(52,109)
LOSS BEFORE INCOME TAX INCLUDING SHARE OF RESULT OF INVESTEE COMPANY	(132,162)	(47,457)
TAXATION	(3,704)	(7,152)
NET LOSS	(135,866)	(54,609)
Other comprehensive income:
- Foreign currency translation adjustment
TOTAL COMPREHENSIVE LOSS	$ (135,866)	$ (54,609)
Net loss per share- Basic and diluted	$ (0.00)	$ (0.00)
Weighted average number of common shares outstanding - Basic and diluted	376,275,500	371,350,000

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - 3 months ended Sep. 30, 2018 - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Comprehensive Loss [Member]	Accumulated Losses [Member]	Total
Balance at Jun. 30, 2018	$ 37,628	$ 5,293,082	$ (1,293)	$ (230,636)	$ 5,098,781
Balance, shares at Jun. 30, 2018	376,275,600
Net loss				(135,866)	(135,866)
Balance at Sep. 30, 2018	$ 37,628	$ 5,293,082	$ (1,293)	$ (366,502)	$ 4,962,915
Balance, shares at Sep. 30, 2018	376,275,600

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (135,866)	$ (54,609)
Adjustments to reconcile net loss to net cash used in operating activities:
Share of result of investee company	52,109
Changes in operating assets and liabilities:
Accounts receivables	(13,264)	(490,466)
Prepayments and deposits	(107,250)
Accounts payables	47,641	387,052
Other payables and accrued liabilities	(12,000)	(8,000)
Deposit received	471,931
Income tax provision	3,704	7,152
Amount due to director		3,846
Net cash provided by/(used in) operating activities	307,005	(155,025)
Net change in cash and cash equivalents	307,005	(155,025)
Cash and cash equivalents, beginning of period	3,531,255	2,312,748
CASH AND CASH EQUIVALENTS, END OF PERIOD	3,838,260	2,157,723
SUPPLEMENTAL CASH FLOWS INFORMATION
Income taxes paid
Interest paid

XML

Description of Business and Organization

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Description of Business and Organization

1. DESCRIPTION OF BUSINESS AND ORGANIZATION

Agape ATP Corporation was incorporated on June 1, 2016 under the laws of the state of Nevada.

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

The Company and its subsidiaries are engaged in providing services in the Health and Wellness Industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries and investee company:

	Subsidiary company name	Place and date of incorporation	Particulars of issued capital	Principal activities	Proportional of ownership interest and voting power held
1.	Agape ATP Corporation	Labuan, March 6, 2017	1 share of ordinary share of US$1 each	Investment holding		100	%
2.	Agape ATP International Holding Limited	Hong Kong, June 1, 2017	1 share of ordinary share of HK$1 each	Health and wellness products and health solution advisory services		100	%

	Investee company name	Place and date of incorporation	Particulars of issued capital	Principal activities	Proportional of ownership interest and voting power held
1.	Unreserved Sdn Bhd	Malaysia, August 25, 2008	500,000 shares of ordinary share of RM7 each	Magazines publication and advertising		20	%

(1) Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of these entities unilaterally, and hence the Company has control over these entities.

XML

Summary of Significant Accounting Policies

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The consolidated financial statements for Agape ATP Corporation and its subsidiaries for the year ended September 30, 2018 and 2017 are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of Agape ATP Corporation and its wholly owned subsidiaries, Agape ATP Corporation and Agape ATP International Holding Limited. Intercompany accounts and transactions have been eliminated in consolidation. The Company has adopted June 30 as its fiscal year end.

Basis of consolidation

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company accounts and transactions have been eliminated upon consolidation.

Use of estimates

Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.

Cash and cash equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents.

Accounts receivable

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

Investment in investee company

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

Investment in marketable securities

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

Deposit received

Deposit received refers to payment received in advance for products which have not yet been delivered. Deposits received is classified on the consolidated balance sheet as current liability.

Revenue recognition

In accordance with Accounting Standards Codification (“ASC”) Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there were no sales return for the three months September 30, 2018.

Cost of revenue

Cost of revenue includes the purchase cost of manufactured goods for sale to customers. It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

Selling, general, administrative and operating expenses

Selling, general, administrative and operating expenses are primarily comprised of travelling and accommodation fees such as petrol, toll and parking.

Income taxes

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

Net income/(loss) per share

The Company calculates net income/(loss) per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

Related parties

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

Foreign currencies translation

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”). In addition, the Company’s subsidiaries in Hong Kong maintain its books and record in its local currency, Hong Kong Dollars (“HKD$”) and Malaysian Ringgit (“MYR”) is the functional currency as being the primary currency of the economic environment in which the entity operates.

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

Translation of amounts from MYR into US$1 and HKD$ into US$1 have been made at the following exchange rates for the respective periods:

	As of and for the three months ended September 30
	2018		2017
Period-end MYR : US$1 exchange rate		4.14		4.22
Period-average MYR : US$1 exchange rate		4.09		4.26
Period-end HKD$ : US$1 exchange rate		7.83		7.81
Period-average HKD$ : US$1 exchange rate		7.85		7.81

Fair value of financial instruments:

The carrying value of the Company’s financial instruments: cash and cash equivalents, account receivables, deposits and prepayment, amount due to a director, and accounts payable and approximate at their fair values because of the short-term nature of these financial instruments.

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Recent accounting pronouncements

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

XML

Common Stock

3 Months Ended

Sep. 30, 2018

Equity [Abstract]

Common Stock

3. COMMON STOCK

As of September 30, 2018 and June 30, 2018, there are 376,275,500 shares with par value of $0.0001 each of common stock issued and outstanding. There was no common stock issued and outstanding from initial public offering in the period as of September 30, 2018.

There were no stock options, warrants or other potentially dilutive securities outstanding as of September 30, 2018.

XML

Investment in Investee Company

3 Months Ended

Sep. 30, 2018

Investments Schedule [Abstract]

Investment in Investee Company

4. INVESTMENT IN INVESTEE COMPANY

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. The investment is stated at cost plus profit share in the investee company as at September 30, 2018. Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim, Ms Aniza Helina Akmi Karim, and Mr How Kok Choong are the directors of Unreserved Sdn Bhd. Mr How Kok Choong is the common director of Unreserved Sdn Bhd and the Company.

	As of September 30, 2018			As of June 30, 2018
Cost of investment	$	862,490		$	862,490
Less: share of result of investee company		(82,264	)		(30,155	)
Investment in investee company	$	780,226		$	832,335

XML

Investment in Marketable Securities

3 Months Ended

Sep. 30, 2018

Investments, Debt and Equity Securities [Abstract]

Investment in Marketable Securities

5. INVESTMENT IN MARKETABLE SECURITIES

At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.

	As of September 30, 2018		As of June 30, 2018
Cost of investment	$	500,000	$	500,000
Investment in marketable securities	$	500,000	$	500,000

XML

Cash and Cash Equivalents

3 Months Ended

Sep. 30, 2018

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents

6. CASH AND CASH EQUIVALENTS

As at September 30, 2018, the Company recorded $3,838,260 of cash and cash equivalents which consists of $1,413,947 of cash on hand and $2,424,313 of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits is 2.95% per annum.

XML

Accounts Receivables

3 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Accounts Receivables

7. ACCOUNT RECEIVABLES

Account receivables consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Account receivables	$	13,264	$	-
Total account receivables	$	13,264	$	-

XML

Prepayments and Deposits

3 Months Ended

Sep. 30, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepayments and Deposits

8. PREPAYMENTS AND DEPOSITS

Prepayments and deposits consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Prepaid expenses	$	7,217	$	11,018
Deposits to supplier		364,974		253,923
Total prepaid expenses and deposits	$	372,191	$	264,941

XML

Trade Payable

3 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Trade Payable

9. TRADE PAYABLE

Trade payable consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Trade payable	$	47,641	$	-
Total trade payable	$	47,641	$	-

XML

Other Payables and Accrued Liabilities

3 Months Ended

Sep. 30, 2018

Other Liabilities Disclosure [Abstract]

Other Payables and Accrued Liabilities

10. OTHER PAYABLES AND ACCRUED LIABILITIES

Other payables and accrued liabilities consisted of the following at September 30, 2018 and June 30, 2017:

	As of September 30, 2018		As of June 30, 2018
Accrued audit fees	$	7,000	$	19,000
Accrued professional fees		749		749
Total payables and accrued liabilities	$	7,749	$	19,749

XML

Deposit Received

3 Months Ended

Sep. 30, 2018

Banking and Thrift [Abstract]

Deposit Received

11. DEPOSIT RECEIVED

Deposit received consisted of the following at September 30, 2018 and June 30, 2017:

	As of September 30, 2018		As of June 30, 2018
Deposit received from customer	$	471,931	$	-
Total deposit received	$	471,931	$	-

XML

Related Party Transaction

3 Months Ended

Sep. 30, 2018

Related Party Transactions [Abstract]

Related Party Transaction

12. RELATED PARTY TRANSACTIONS

	Three Months Ended September 30, 2018		Three Months Ended September 30, 2017
Revenue:
- Related Party A	$	415,367	$	490,126
Amount due to related party:
- Related Party A	$	745	$	-
Company Secretary Fee:
- Related Party B	$	802	$	-

The director of related party A is the CEO and the Director of the Company.

Related party B is a 4.7% shareholder of the Company.

XML

Amount Due to a Director

3 Months Ended

Sep. 30, 2018

Related Party Transactions [Abstract]

Amount Due to a Director

13. AMOUNT DUE TO A DIRECTOR

As of September 30, 2018 and June 30, 2017, a director of the Company advanced $3,922 to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

XML

Income Taxes

3 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

14. INCOME TAXES

For the three months ended September 30, 2018 and 2017, the local (United States) and foreign components of income/(loss) before income taxes were comprised of the following:

	Three Months Ended September 30
	2018			2017
Tax jurisdictions from:
- Local	$	(21,497	)	$	(90,745	)
- Foreign, representing
Labuan, Malaysia		(81,004	)		(58	)
Hong Kong		(29,661	)		43,346
Loss before income tax	$	(132,162	)	$	(47,457	)

The provision for income taxes consisted of the following:

	Three Months Ended September 30
	2018		2017
Current:
- Local	$	-	$	-
- Foreign		3,704		7,152
Deferred:
- Local		-		-
- Foreign		-		-
Income tax expense	$	3,704	$	7,152

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

United States of America

Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2018, the operations in the United States of America incurred $383,615 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for September 30, 2018 and June 30, 2018 are $76,559 and $76,045 respectively.

Labuan

Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit or at a fixed rate of RM20,000.

Hong Kong

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income. The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2018 and June 30, 2018:

	As of September 30, 2018			As of June 30, 2018
	(unaudited)			(audited)
Deferred tax assets:
Net operating loss carry forwards
- United States of America	$	76,559		$	76,045
- Hong Kong		-			-
Less: valuation allowance	$	(76,559	)	$	(76,045	)
Deferred tax assets	$	-		$	-

XML

Concentrations of Risks

3 Months Ended

Sep. 30, 2018

Risks and Uncertainties [Abstract]

Concentrations of Risks

15. CONCENTRATIONS OF RISK

The Company is exposed to the following concentrations of risk:

(a) Major customers

For three months ended September 30, 2018 and 2017, the customers who accounted for 10% or more of the Company’s sales and its outstanding receivable balance at period-end are presented as follows:

	2018		2017		2018			2017			2018		2017
	Revenues				Percentage of revenues						Accounts receivable, trade
Customer A	$	415,367	$	490,126		100	%		100	%	$	13,264	$	490,466
	$	415,367	$	490,126		100	%		100	%	$	13,264	$	490,466

(b) Major vendors

For three months ended September 30, 2018 and 2017, the vendors who accounted for 10% or more of the Company’s purchases and its outstanding payable balance at period-end are presented as follows:

	2018		2017		2018			2017			2018		2017
	Purchases				Percentage of purchases						Accounts payable, trade
Vendor A	$	314,423	$	444,238		83	%		100	%	$	47,641	$	387,052
Vendor B	$	64,000	$	-		17	%		-	%	$	-	$	-
	$	378,423	$	444,238		100	%		100	%	$	47,641	$	387,052

XML

Subsequent Events

3 Months Ended

Sep. 30, 2018

Subsequent Events [Abstract]

Subsequent Events

16. SUBSEQUENT EVENTS

The Company has evaluated subsequent events from the balance sheet date through November 14, 2018, the date the Company issued unaudited consolidated financial statements in accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued. During this period, there was no subsequent event that required recognition or disclosure.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Basis of Presentation

Basis of presentation

The consolidated financial statements for Agape ATP Corporation and its subsidiaries for the year ended September 30, 2018 and 2017 are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of Agape ATP Corporation and its wholly owned subsidiaries, Agape ATP Corporation and Agape ATP International Holding Limited. Intercompany accounts and transactions have been eliminated in consolidation. The Company has adopted June 30 as its fiscal year end.

Basis of Consolidation

Basis of consolidation

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company accounts and transactions have been eliminated upon consolidation.

Use of Estimates

Use of estimates

Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.

Cash and Cash Equivalents

Cash and cash equivalents

The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents.

Accounts receivable

Accounts receivable

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

Investment in Investee Company

Investment in investee company

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

Investment in Marketable Securities

Investment in marketable securities

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale. 

Deposit Received

Deposit received

Deposit received refers to payment received in advance for products which have not yet been delivered. Deposits received is classified on the consolidated balance sheet as current liability.

Revenue Recognition

Revenue recognition

In accordance with Accounting Standards Codification (“ASC”) Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there were no sales return for the three months September 30, 2018.

Cost of Revenue

Cost of revenue

Cost of revenue includes the purchase cost of manufactured goods for sale to customers. It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

Selling, General, Administrative and Operating Expenses

Selling, general, administrative and operating expenses

Selling, general, administrative and operating expenses are primarily comprised of travelling and accommodation fees such as petrol, toll and parking.

Income taxes

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

Income Taxes

Income taxes

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

Net Income/(loss) Per Share

Net income/(loss) per share

The Company calculates net income/(loss) per share in accordance with ASC Topic 260, “Earnings per Share.” Basic income/(loss) per share is computed by dividing the net income/(loss) by the weighted-average number of common shares outstanding during the period. Diluted income per share is computed similar to basic income/(loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

Related Parties

Related parties

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

Foreign Currencies Translation

Foreign currencies translation

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”). In addition, the Company’s subsidiaries in Hong Kong maintain its books and record in its local currency, Hong Kong Dollars (“HKD$”) and Malaysian Ringgit (“MYR”) is the functional currency as being the primary currency of the economic environment in which the entity operates.

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

Translation of amounts from MYR into US$1 and HKD$ into US$1 have been made at the following exchange rates for the respective periods:

	As of and for the three months ended September 30
	2018		2017
Period-end MYR : US$1 exchange rate		4.14		4.22
Period-average MYR : US$1 exchange rate		4.09		4.26
Period-end HKD$ : US$1 exchange rate		7.83		7.81
Period-average HKD$ : US$1 exchange rate		7.85		7.81

Fair Value of Financial Instruments

Fair value of financial instruments:

The carrying value of the Company’s financial instruments: cash and cash equivalents, account receivables, deposits and prepayment, amount due to a director, and accounts payable and approximate at their fair values because of the short-term nature of these financial instruments.

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Recent Accounting Pronouncements

Recent accounting pronouncements

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

XML

Description of Business and Organization (Tables)

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Schedule of Subsidiaries and Associates

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries and investee company:

	Subsidiary company name	Place and date of incorporation	Particulars of issued capital	Principal activities	Proportional of ownership interest and voting power held
1.	Agape ATP Corporation	Labuan, March 6, 2017	1 share of ordinary share of US$1 each	Investment holding		100	%
2.	Agape ATP International Holding Limited	Hong Kong, June 1, 2017	1 share of ordinary share of HK$1 each	Health and wellness products and health solution advisory services		100	%

	Investee company name	Place and date of incorporation	Particulars of issued capital	Principal activities	Proportional of ownership interest and voting power held
1.	Unreserved Sdn Bhd	Malaysia, August 25, 2008	500,000 shares of ordinary share of RM7 each	Magazines publication and advertising		20	%

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Schedule of Translation Exchange Rates

Translation of amounts from MYR into US$1 and HKD$ into US$1 have been made at the following exchange rates for the respective periods:

	As of and for the three months ended September 30
	2018		2017
Period-end MYR : US$1 exchange rate		4.14		4.22
Period-average MYR : US$1 exchange rate		4.09		4.26
Period-end HKD$ : US$1 exchange rate		7.83		7.81
Period-average HKD$ : US$1 exchange rate		7.85		7.81

XML

Investment in Investee Company (Tables)

3 Months Ended

Sep. 30, 2018

Investments Schedule [Abstract]

Schedule of Investments

	As of September 30, 2018			As of June 30, 2018
Cost of investment	$	862,490		$	862,490
Less: share of result of investee company		(82,264	)		(30,155	)
Investment in investee company	$	780,226		$	832,335

XML

Investment in Marketable Securities (Tables)

3 Months Ended

Sep. 30, 2018

Investments, Debt and Equity Securities [Abstract]

Schedule of Investment in Marketable Securities

	As of September 30, 2018			As of June 30, 2018
Cost of investment	$	862,490		$	862,490
Less: share of result of investee company		(82,264	)		(30,155	)
Investment in investee company	$	780,226		$	832,335

XML

Accounts Receivables (Tables)

3 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Schedule of Account Receivable

Account receivables consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Account receivables	$	13,264	$	-
Total account receivables	$	13,264	$	-

XML

Prepayments and Deposits (Tables)

3 Months Ended

Sep. 30, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Prepaid Expenses and Deposits

Prepayments and deposits consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Prepaid expenses	$	7,217	$	11,018
Deposits to supplier		364,974		253,923
Total prepaid expenses and deposits	$	372,191	$	264,941

XML

Trade Payable (Tables)

3 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Schedule of Trade payable

Trade payable consisted of the following at September 30, 2018 and June 30, 2018:

	As of September 30, 2018		As of June 30, 2018
Trade payable	$	47,641	$	-
Total trade payable	$	47,641	$	-

XML

Other Payables and Accrued Liabilities (Tables)

3 Months Ended

Sep. 30, 2018

Other Liabilities Disclosure [Abstract]

Schedule of Other Payables and Accrued Liabilities

Other payables and accrued liabilities consisted of the following at September 30, 2018 and June 30, 2017:

	As of September 30, 2018		As of June 30, 2018
Accrued audit fees	$	7,000	$	19,000
Accrued professional fees		749		749
Total payables and accrued liabilities	$	7,749	$	19,749

XML

Deposit Received (Tables)

3 Months Ended

Sep. 30, 2018

Banking and Thrift [Abstract]

Schedule of Deposit Received

Deposit received consisted of the following at September 30, 2018 and June 30, 2017:

	As of September 30, 2018		As of June 30, 2018
Deposit received from customer	$	471,931	$	-
Total deposit received	$	471,931	$	-

XML

Related Party Transaction (Tables)

3 Months Ended

Sep. 30, 2018

Related Party Transactions [Abstract]

Schedule of Related Party Transactions

	Three Months Ended September 30, 2018		Three Months Ended September 30, 2017
Revenue:
- Related Party A	$	415,367	$	490,126
Amount due to related party:
- Related Party A	$	745	$	-
Company Secretary Fee:
- Related Party B	$	802	$	-

XML

Income Taxes (Tables)

3 Months Ended

Sep. 30, 2018

Income Tax Disclosure [Abstract]

Schedule of Components of Income/(Loss) Before Income Tax

For the three months ended September 30, 2018 and 2017, the local (United States) and foreign components of income/(loss) before income taxes were comprised of the following:

	Three Months Ended September 30
	2018			2017
Tax jurisdictions from:
- Local	$	(21,497	)	$	(90,745	)
- Foreign, representing
Labuan, Malaysia		(81,004	)		(58	)
Hong Kong		(29,661	)		43,346
Loss before income tax	$	(132,162	)	$	(47,457	)

Schedule of Provision for Income Tax

The provision for income taxes consisted of the following:

	Three Months Ended September 30
	2018		2017
Current:
- Local	$	-	$	-
- Foreign		3,704		7,152
Deferred:
- Local		-		-
- Foreign		-		-
Income tax expense	$	3,704	$	7,152

Schedule of Deferred Tax Assets

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2018 and June 30, 2018:

	As of September 30, 2018			As of June 30, 2018
	(unaudited)			(audited)
Deferred tax assets:
Net operating loss carry forwards
- United States of America	$	76,559		$	76,045
- Hong Kong		-			-
Less: valuation allowance	$	(76,559	)	$	(76,045	)
Deferred tax assets	$	-		$	-

XML

Concentrations of Risks (Tables)

3 Months Ended

Sep. 30, 2018

Risks and Uncertainties [Abstract]

Schedule of Concentrations of Risks

(a) Major customers

For three months ended September 30, 2018 and 2017, the customers who accounted for 10% or more of the Company’s sales and its outstanding receivable balance at period-end are presented as follows:

	2018		2017		2018			2017			2018		2017
	Revenues				Percentage of revenues						Accounts receivable, trade
Customer A	$	415,367	$	490,126		100	%		100	%	$	13,264	$	490,466
	$	415,367	$	490,126		100	%		100	%	$	13,264	$	490,466

(b) Major vendors

For three months ended September 30, 2018 and 2017, the vendors who accounted for 10% or more of the Company’s purchases and its outstanding payable balance at period-end are presented as follows:

	2018		2017		2018			2017			2018		2017
	Purchases				Percentage of purchases						Accounts payable, trade
Vendor A	$	314,423	$	444,238		83	%		100	%	$	47,641	$	387,052
Vendor B	$	64,000	$	-		17	%		-	%	$	-	$	-
	$	378,423	$	444,238		100	%		100	%	$	47,641	$	387,052

XML

Description of Business and Organization (Details Narrative)	Sep. 30, 2018
Agape ATP International Holding Limited [Member]
Ownership percentage	100.00%

XML

Description of Business and Organization - Schedule of Subsidiaries and Associates (Details)	3 Months Ended
	Sep. 30, 2018
Subsidiary Company [Member]
Company name	Agape ATP Corporation
Place and date of incorporation	Labuan,March 6, 2017
Particulars of issued capital	1 share of ordinary share of US$1 each
Principal activities	Investment holding
Proportional of ownership interest and voting power held	100.00%
Subsidiary Company One [Member]
Company name	Agape ATP International Holding Limited
Place and date of incorporation	Hong Kong, June 1, 2017
Particulars of issued capital	1 share of ordinary share of HK$1 each
Principal activities	Health and wellness products and health solution advisory services
Proportional of ownership interest and voting power held	100.00%
Invetsee Company [Member] | Unreserved Sdn Bhd [Member]
Company name	Unreserved Sdn Bhd
Place and date of incorporation	Malaysia, August 25, 2008
Particulars of issued capital	500,000 shares of ordinary share of RM7 each
Principal activities	Magazines publication and advertising
Proportional of ownership interest and voting power held	20.00%

XML

Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details)	Sep. 30, 2018	Sep. 30, 2017
Period-end MYR [Member]
Foreign Curency Exchange Rate, Translation	0.0414	0.0422
Period-average MYR [Member]
Foreign Curency Exchange Rate, Translation	0.0409	0.0426
Period-end HKD [Member]
Foreign Curency Exchange Rate, Translation	0.0783	0.0781
Period-average HKD [Member]
Foreign Curency Exchange Rate, Translation	0.0785	0.0781

XML

Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
MYR [Member]
Exchange rate	$ 1	$ 1
HKD [Member]
Exchange rate	$ 1	$ 1

XML

Common Stock (Details Narrative) - $ / shares	Sep. 30, 2018	Jun. 30, 2018
Common stock par value	$ 0.0001	$ 0.0001
Common stock issued	376,275,500	376,275,500
Common stock outstanding	376,275,500	376,275,500
IPO [Member]
Common stock issued
Common stock outstanding

XML

Investment in Investee Company (Details Narrative) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Investment amount	$ 780,226	$ 832,335
Ordinary shares authorized	1,000,000,000	1,000,000,000
Ordinary shares issued	376,275,500	376,275,500
Ordinary shares outstanding	376,275,500	376,275,500
Director [Member]
Investment amount	$ 862,490
Equity interest percentage	20.00%
Ordinary shares authorized	2,500,000
Ordinary shares issued	2,500,000
Ordinary shares outstanding	2,500,000
Director [Member] | MYR [Member]
Investment amount	$ 3,500,000

XML

Investment in Investee Company - Schedule of Investments (Details) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Investments Schedule [Abstract]
Cost of investment	$ 862,490	$ 862,490
Less: share of result of investee company	(82,264)	(30,155)
Investment in investee company	$ 780,226	$ 832,335

XML

Investment in Marketable Securities (Details Narrative) - USD ($)	Sep. 30, 2018	Jun. 30, 2018	May 17, 2018
Investment amount	$ 780,226	$ 832,335
Greenpro Capital Corp. [Member]
Investment amount			$ 500,000
Purchased price per shares			$ 6

XML

Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]
Cost of investment	$ 862,490	$ 862,490
Investment in marketable securities	$ 500,000	$ 500,000

XML

Cash and Cash Equivalents (Details Narrative) - USD ($)	Sep. 30, 2018	Jun. 30, 2018	Sep. 30, 2017	Jun. 30, 2017
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 3,838,260	$ 3,531,255	$ 2,157,723	$ 2,312,748
Cash on hand	14,139,447
Time deposits	$ 2,424,313
Interest rate	2.95%

XML

Accounts Receivables - Schedule of Account Receivable (Details) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Notes to Financial Statements
Account receivables	$ 13,264
Total account receivables	$ 13,264

XML

Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 7,217	$ 11,018
Deposits to supplier	364,974	253,923
Total prepaid expenses and deposits	$ 372,191	$ 264,941

XML

Trade Payable - Schedule of Trade payable (Details) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Notes to Financial Statements
Trade payable	$ 47,641
Total trade payable	$ 47,641

XML

Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Other Liabilities Disclosure [Abstract]
Accrued audit fees	$ 7,000	$ 19,000
Accrued professional fees	749	749
Total payables and accrued liabilities	$ 7,749	$ 19,749

XML

Related Party Transaction (Details Narrative)	Sep. 30, 2018
Related Party B [Member]
Ownership percentage	4.70%

XML

Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018
Revenue	$ 415,367	$ 490,126
Amount due to related party	745		$ 745
Related Party A [Member]
Revenue	415,367	490,126
Amount due to related party	745
Related Party B [Member]
Company secretary fee	$ 802

XML

Amount Due to a Director (Details Narrative) - USD ($)	Sep. 30, 2018	Jun. 30, 2018	Sep. 30, 2017
Due to related party	$ 3,922	$ 3,922
Director [Member]
Due to related party	$ 3,922		$ 3,922

XML

Income Taxes (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018
United States of America [Member]
Cumulative net operating loss	$ 383,615
Operating loss carryforwards expire year	2038
Valuation allowance	$ 76,559	$ 76,045
Labuan [Member]
Tax percentage	3.00%
Labuan [Member] | MYR [Member]
Fixed rate of foreign income tax amount	$ 20,000
Hong Kong [Member]
Statutory income tax rate	16.50%

XML

Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Local	$ (21,497)	$ (90,745)
Loss before income tax	(80,053)	(47,457)
Labuan [Member]
Foreign	(81,004)	(58)
Hong Kong [Member]
Foreign	$ (29,661)	$ 43,346

XML

Income Taxes - Schedule of Provision for Income Tax (Details) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Current, Local
Current, Foreign	3,704	7,152
Deferred, Local
Deferred, Foreign
Income tax expense	$ 3,704	$ 7,152

XML

Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Less: valuation allowance	$ (76,559)	$ (76,045)
Deferred tax asset
United States of America [Member]
Net operating loss carryforwards	76,559	76,045
Hong Kong [Member]
Net operating loss carryforwards

XML

Concentrations of Risks - Schedule of Concentrations of Risks (Details) - USD ($)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018
Revenues	$ 415,367	$ 490,126
Accounts receivable, trade	13,264
Purchase	378,423	$ 444,238
Accounts payable, trade	$ 47,641
Accounts Payable [Member]
Concentrations of risk percentage	100.00%	100.00%
Accounts payable, trade	$ 47,641	$ 387,052
Vendor A [Member] | Accounts Payable [Member]
Accounts receivable, trade	47,641	387,052
Accounts payable, trade	47,641	387,052
Vendor B [Member] | Accounts Payable [Member]
Accounts receivable, trade
Accounts payable, trade
Sales Revenue, Net [Member]
Revenues	415,367	490,126
Sales Revenue, Net [Member] | Customer A [Member]
Revenues	$ 415,367	$ 490,126
Concentrations of risk percentage	100.00%	100.00%
Accounts Receivable [Member]
Concentrations of risk percentage	100.00%	100.00%
Accounts receivable, trade	$ 13,264	$ 490,466
Accounts Receivable [Member] | Customer A [Member]
Accounts receivable, trade	13,264	13,264
Cost of Sales [Member]
Purchase	378,423	444,238
Cost of Sales [Member] | Vendor A [Member]
Revenues	$ 314,423	$ 444,238
Concentrations of risk percentage	83.00%	100.00%
Purchase	$ 314,423	$ 444,238
Cost of Sales [Member] | Vendor B [Member]
Revenues	$ 64,000
Concentrations of risk percentage	17.00%	0.00%
Purchase	$ 64,000

XML

Concentrations of Risks - Schedule of Concentrations of Risks (Details) (Parenthetical)	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Customer [Member]
Concentrations of risk percentage	10.00%	10.00%
Vendor [Member]
Concentrations of risk percentage	10.00%	10.00%